TerrAscend (TSNDF) Intangibles (2021 - 2026)
TerrAscend's (TSNDF) quarterly Intangibles came in at $211.1 million in Q1 2026, up 47.35% year-on-year from $143.3 million in Q1 2025, and up 801.49% on a QoQ basis from $23.4 million in Q4 2025.
TerrAscend (TSNDF) Intangibles (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Intangibles data on file, last reported at $211.1 million in Q1 2026.
- On a quarterly basis, Intangibles rose 47.35% year-over-year to $211.1 million in Q1 2026; TTM through Mar 2026 was $211.1 million, a 47.35% increase from a year earlier, with the FY2025 full-year figure at $23.4 million, down 5.45% from the prior year.
- Intangibles for Q1 2026 stood at $211.1 million, up from $23.4 million in the prior quarter.
- Over the last five years, Intangibles for TSNDF reached as high as $371.4 million in Q2 2022 and fell as low as $4.8 million in Q2 2023.
- Historically, Intangibles has averaged $134.5 million across 5 years, with a median of $143.3 million in 2025.
- Across the five-year window, Intangibles plunged 98.71% in 2023 and soared 3349.53% in 2024, its largest moves.
- Year by year, Intangibles stood at $82.8 million in 2022, then slumped by 41.86% to $48.1 million in 2023, then sank by 48.52% to $24.8 million in 2024, then decreased by 5.45% to $23.4 million in 2025, then soared by 801.49% to $211.1 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $211.1 million in Q1 2026, $23.4 million in Q4 2025, and $171.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 211.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211.15 Mn |
| Dec 31, 2025 | 23.42 Mn |
| Sep 30, 2025 | 171.56 Mn |
| Jun 30, 2025 | 202.00 Mn |
| Mar 31, 2025 | 143.29 Mn |
| Dec 31, 2024 | 24.77 Mn |
| Sep 30, 2024 | 163.73 Mn |
| Jun 30, 2024 | 165.54 Mn |
| Mar 31, 2024 | 167.09 Mn |
| Dec 31, 2023 | 48.12 Mn |
| Sep 30, 2023 | 82.76 Mn |
| Jun 30, 2023 | 4.80 Mn |
| Mar 31, 2023 | 82.76 Mn |
| Dec 31, 2022 | 82.76 Mn |
| Sep 30, 2022 | 259.45 Mn |
| Jun 30, 2022 | 371.37 Mn |
| Mar 31, 2022 | 82.21 Mn |
| Dec 31, 2021 | 24.77 Mn |